TrialX
Advanced Filters
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
noise

Found 2,831 clinical trials

Q Q3 A3

PCSK9i in AAA1234

Please see section 3 of the full protocol Please see section 3 of the full protocol Please see section 3 of the full protocol

99 years and younger All Phase N/A
Q Q3 A3

PCSK9i in AAA1235

Please see section 3 of the full protocol Please see section 3 of the full protocol Please see section 3 of the full protocol

99 years and younger All Phase N/A

UPENN Case Test Trial 2 (Do Not Make Any Changes)

UPENN Case Test Trial 2 (Do Not Make Any Changes)

100 years and younger All Phase N/A
U Upenn Site User 7

UPENN Case Test Trial 4 (Do Not Make Any Changes)

UPENN Case Test Trial 4 (Do Not Make Any Changes)

100 years and younger All Phase N/A
U Upenn Site User 7

UPENN Case Test Trial 5 (Do Not Make Any Changes)

UPENN Case Test Trial 5 (Do Not Make Any Changes)

100 years and younger All Phase N/A
U Upenn Site User 6

UPENN Case Test Trial 7 (Do Not Make Any Changes)

UPENN Case Test Trial 7 (Do Not Make Any Changes)

100 years and younger All Phase N/A
U Upenn Site User 11

UPENN Case Test Trial 12 (Do Not Make Any Changes)

UPENN Case Test Trial 12 (Do Not Make Any Changes)

100 years and younger All Phase N/A
U UPENN Site User 1

UPENN Case Test Trial 13 (Do Not Make Any Changes)

UPENN Case Test Trial 13 (Do Not Make Any Changes)

100 years and younger All Phase N/A
A Alayna P. Tackett, PhD

change - Safety and Tolerability of TOP-N53 Applied on Digital Ulcers in Patients With Systemic Sclerosis

change - The main goal of this clinical trial is to learn about how safe the new drug TOP-N53 solution is when it is applied to open wounds on the fingertip (digital ulcers) in people with an uncommon illness that results in hard, thickened areas of skin and additional problems …

18-69 years All Phase 2
B Bin Xiong

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Gastric Cancer

The efficacy of HIPEC in prevention of local recurrence, distant metastasis or peritoneal metastasis in locally advanced gastric cancer is not definite. The hypothesis of the trial is that radical gastrectomy combined with HIPEC is superior to only radical gastrectomy in terms of overall survival.

18-75 years All Phase 2

Simplify language using AI